Correcting a Sickle Cell Mutation with Efficient CRISPR-Cas9 Genome Editing
Collaborative research effort reduces off-target CRISPR-Cas9 genome editing, removing barriers for human therapeutic applications
Collaborative research effort reduces off-target CRISPR-Cas9 genome editing, removing barriers for human therapeutic applications
Reduction of CRISPR off-target effects without significant loss of on-target activity
Expanded CRISPR toolkit includes Cpf1 and range of Alt-R™ support products, increasing the options available to molecular biology researchers
Innovative product development exemplifies commitment to sustainability—reduces waste and saves costs
Company now selling directly to customers in South Korea
Life science companies combine expertise to enhance transcriptome research
Insightful harnessing of the natural crRNA:tracrRNA complex with the new Alt-R™ CRISPR-Cas9 System
IDT demonstrates how to enhance research methods with innovative new DNA tools
Launches IDT ISO 14001 Sustainability Award to support local research and environmental sustainability